Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer.
Journal Information
Full Title: Korean J Radiol
Abbreviation: Korean J Radiol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"availability of data and material the datasets generated or analyzed during the study are available from the corresponding author on reasonable request. supplement the supplement is available with this article at https://doi"
"Conflicts of Interest: Han-Byoel Lee is a co-founder and a member of the board of directors at DCGen Co., Ltd. Han-Byoel Lee received research funding from Devicor Medical Product, Inc., and consulting fees and honoraria from Alvogen, Boryung, Lilly, Novartis, Roche, Takeda, and Celltrion Pharm, outside of the current study. Other authors have no potential conflicts of interest to disclose."
"Funding Statement: None"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025